Our mission is to rule in or out ovarian cancer and improve the management of women with pelvic masses.
We developed OvaPrint™, a circulating tumor DNA blood test, designed to diagnose ovarian cancer pre-operatively in woman with a pelvic mass. It also works on early stage ovarian cancer, overcoming problems with existing tests.
Currently, tissue taken after surgery is the only way to diagnose ovarian cancer.
Detecting ovarian cancer prior to surgery can ensure women with pelvic masses are being appropriately referred to the right doctor.